[HTML][HTML] Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies

…, E Lee, PC Cremer, B Carey, P Rajendram… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that
often leads to respiratory failure, need for mechanical ventilation, and death. Most of the lung …

Addressing caregiver moral distress during the COVID-19 pandemic.

G Morley, D Sese, P Rajendram… - Cleveland Clinic journal …, 2020 - europepmc.org
Moral distress is the psychological distress that is experienced in relation to a morally
challenging situation or event. Although it was first observed within nursing, caregivers across all …

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind …

…, B Carey, Q Wang, KE Wolski, P Rajendram… - The Lancet …, 2021 - thelancet.com
Background In patients with COVID-19, granulocyte-macrophage colony stimulating factor (GM-CSF)
might be a mediator of the hyperactive inflammatory response associated with …

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in …

…, D Brennan, DA Culver, P Rajendram… - Clinical …, 2020 - Wiley Online Library
Background In patients with Covid‐19, myocardial injury and increased inflammation are
associated with morbidity and mortality. We designed a proof‐of‐concept randomized …

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

…, MM Herr, SS Kadri, B Hill, P Rajendram… - Journal of critical …, 2020 - Elsevier
Purpose A task force of experts from 11 United States (US) centers, sought to describe
practices for managing chimeric antigen receptor (CAR) T-cell toxicity in the intensive care unit (…

Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation

…, DA Wolinsky, DA Culver, P Rajendram… - … Heart Journal Open, 2021 - academic.oup.com
Aims In coronavirus disease 2019 (COVID-19), myocardial injury is associated with systemic
inflammation and higher mortality. Our aim was to perform a proof of concept trial with …

[HTML][HTML] A high neutrophil-lymphocyte ratio is associated with increased morbidity and mortality in patients with coronavirus disease 2019

AH King, O Mehkri, P Rajendram, X Wang… - Critical Care …, 2021 - journals.lww.com
Objectives: The neutrophil-lymphocyte ratio is an inexpensive and simple inflammatory marker.
A higher ratio, indicative of an acute hyperinflammatory response or diminished overall …

Characteristics and outcomes of ethics consultations in an oncologic intensive care unit

LP Voigt, P Rajendram, AG Shuman… - Journal of intensive …, 2015 - journals.sagepub.com
Objective: To evaluate the frequency, characteristics, and outcomes of ethics consultations
in critically ill patients with cancer. Design, Setting, and Methods: This is a retrospective …

[HTML][HTML] Tocilizumab in coronavirus disease 2019-related critical illness: a propensity matched analysis

P Rajendram, GL Sacha, O Mehkri, X Wang… - Critical care …, 2021 - journals.lww.com
Objectives: The primary objective was to evaluate ICU mortality at 28 days in patients with
severe hypoxemic respiratory failure due to coronavirus disease 2019 infection who received …

[HTML][HTML] Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2

…, P Srinivas, T Asadi, C Calabrese, P Rajendram… - American Journal of …, 2020 - Elsevier
There are emerging data depicting the clinical presentation of coronavirus disease 19 (COVID-19)
in solid organ transplant recipients but negligible data-driven guidance on clinical …